Prevalence of premalignant and malignant changes in hysteroscopically removed endometrial polyps in reproductive aged women: A 5-year review of cases in a Tertiary Government Hospital in the Philippines
- Author:
Maria Angela B. de de Castro-Abesamis
1
;
Chiaoling Sua Lao
1
Author Information
- Publication Type:Journal Article
- Keywords: Endometrial poly; Abnormal uterine bleeding
- MeSH: Hysteroscopy; Endometrial Neoplasms; Endometrial Hyperplasia
- From: Philippine Journal of Reproductive Endocrinology and Infertility 2022;19(2):31-
- CountryPhilippines
- Language:English
-
Abstract:
Objective:To determine the prevalence of premalignant and malignant changes in
hysteroscopically removed endometrial polyps in reproductive aged women, and to determine
clinical, ultrasonographic and hysteroscopic characteristics of such women.
Methods:This is a cross-sectional study of patients diagnosed with endometrial polyp, and underwent hysteroscopy from 2015-2019. A review of the medical records (ultrasound results, intraoperative findings and histopathology results) was done.
Results:A total of 117 patient records were included in the analysis. The median age of all patients who underwent hysteroscopy was 38 years old (age range: 19-44 years). The prevalence of endometrial hyperplasia or carcinoma in the 18-44 year old age group was 8.5% (n=10/117). Among patients with endometrial hyperplasia or carcinoma, 70% were nulligravid, 40% had anovulation disorder, and 40% had infertility. Most of the patients were overweight or obese (70%). Co-morbidities were present in only 3 cases, and diabetes mellitus (30%) was the predominant illness seen in these patients.
Conclusion:Our findings showed a higher prevalence (8.5%) of endometrial hyperplasia or carcinoma in endometrial polyps among Filipino reproductive-aged women, compared to reports in published literature. Among the different clinical characteristics, ultrasound and hysteroscopic findings, no particular factor had a significant association with endometrial hyperplasia or malignancy. - Full text:abesamis_PJREI 2022.pdf
